Caro, J. Jaime
Brazier, John E.
Karnon, Jonathan
Kolominsky-Rabas, Peter
McGuire, Alistair J.
Nord, Erik
Schlander, Michael
Funding for this research was provided by:
Janssen Pharmaceuticals (xxx)
Article History
First Online: 9 November 2018
Compliance with Ethical Standards
:
: J Jaime Caro, John Brazier, Jonathan Karnon, Peter Kolominsky-Rabas, Alistair McGuire, Erik Nord and Michael Schlander declare no financial conflicts of interest. All authors are well known for their views on the subject matter discussed in this paper.
: A meeting in London and subsequent deliberations were supported by an unrestricted grant from Janssen Pharmaceutica. Two senior staff from Janssen were present as observers during the panel meeting; they have had access to the draft versions of this paper and have provided very helpful comments, but neither they nor the company they represent had any editorial control. The agreement with Janssen ensured the authors’ independence in study design, data interpretation, writing, and submitting the manuscript for publication. All decisions regarding the content of this paper and the decision to publish were made independently by the authors.
: J. Jaime Caro will serve as overall guarantor for this study and manuscript. All authors participated in the discussions that led to this paper and in the revisions of all drafts. All authors approved the final version submitted for publication.